“We are unlikely to ever have a randomized controlled trial of oseltamivir in hospitalized children, so high-quality observational data are particularly important for this population,” Suchitra Rao, MBBS, MSCS, professor of pediatrics at University of Colorado School of Medicine and Children’s Hospital Colorado, told Healio.